SAA1 and hepatocellular carcinoma: However, it has not been determined if targeting neutrophil metabolism is synergistic with cancer immunotherapy or if SAA contributes to the control of neutrophils in human HCC tumor microenvironments and mediates resistance to PD-1 antibodies.